With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront…
Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close